Bactrim Dosing for Urinary Tract Infection
Standard Adult Dosing for Uncomplicated Cystitis
For non-pregnant adult women with uncomplicated cystitis, prescribe trimethoprim-sulfamethoxazole (Bactrim DS) 160/800 mg orally twice daily for 3 days, but only when local E. coli resistance is documented to be <20% and the patient has not received this antibiotic in the preceding 3–6 months. 1
Women
- Dose: One double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) twice daily 1, 2
- Duration: 3 days 1
- Clinical cure rate: 90–100% when the organism is susceptible 1
- Treatment failure rate: 41–54% when the organism is resistant 1
Men
- Dose: One double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) twice daily 1
- Duration: 7 days (the 3-day regimen studied in women is inadequate for men) 1, 3
Renal Dose Adjustments
When creatinine clearance is reduced, adjust the dose according to the following algorithm: 2
- CrCl >30 mL/min: Standard dose (one DS tablet twice daily) 2
- CrCl 15–30 mL/min: Half-dose (one single-strength tablet or half of a DS tablet twice daily) 2
- CrCl <15 mL/min: Use is not recommended; select an alternative agent 2
Monitoring in Renal Impairment
- Obtain baseline creatinine clearance before initiating therapy 3
- Monitor serum creatinine, BUN, and electrolytes 2–3 times weekly during treatment in patients with renal impairment 3
- Ensure adequate hydration (at least 1.5 liters daily) to prevent crystalluria 3
- Check for hyperkalemia regularly, as trimethoprim can block potassium excretion 3
Pediatric Dosing (≥2 Months of Age)
For children with urinary tract infections, the recommended dose is 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, divided into two doses every 12 hours for 10 days. 2
Weight-Based Dosing Table
- 22 lb (10 kg): ½ tablet every 12 hours 2
- 44 lb (20 kg): 1 tablet every 12 hours 2
- 66 lb (30 kg): 1½ tablets every 12 hours 2
- 88 lb (40 kg): 2 tablets or 1 DS tablet every 12 hours 2
Bactrim is not recommended for pediatric patients less than 2 months of age. 2
Critical Prescribing Criteria and Contraindications
When to Avoid Bactrim Empirically
Do not prescribe trimethoprim-sulfamethoxazole empirically when any of the following conditions exist:
- Local E. coli resistance ≥20%: Treatment failure rates become unacceptably high (cure drops from 90–100% to 41–54%) 1, 4
- Recent exposure: Patient received TMP-SMX within the preceding 3–6 months 1
- Recent international travel: Travel outside the United States within the preceding 3–6 months predicts higher resistance 1
- Last trimester of pregnancy: Contraindicated due to fetal risks 1
- Marked hepatic damage: May exacerbate liver dysfunction 1
When Bactrim Is Inappropriate for Clinical Presentation
- Suspected pyelonephritis: Any fever >38°C, flank pain, costovertebral angle tenderness, nausea, or vomiting requires a fluoroquinolone or cephalosporin instead 5, 3
- Complicated UTI: Structural/functional abnormalities, obstruction, instrumentation, or pregnancy require longer courses and often different agents 5
- Suspected prostatitis in men: TMP-SMX does not penetrate prostatic tissue adequately 5
First-Line Alternative Agents (When Bactrim Cannot Be Used)
When local resistance is ≥20%, resistance data are unavailable, or the patient has contraindications to TMP-SMX, prescribe one of the following:
Nitrofurantoin (Preferred Alternative)
- Dose: 100 mg orally twice daily 5
- Duration: 5 days 5
- Clinical cure rate: 88–93% 5
- Bacteriologic cure rate: 81–92% 5
- Contraindications: CrCl <30 mL/min, suspected pyelonephritis 5
Fosfomycin
- Dose: 3 g as a single oral dose 5, 1
- Clinical cure rate: 90–91% 1
- Advantage: Single-dose convenience 1
Fluoroquinolone (Reserve Agent)
- Ciprofloxacin: 250 mg orally twice daily for 3 days 1
- Bacteriologic eradication: 93–97% 1
- Reserve for: Pyelonephritis or culture-proven resistant organisms due to FDA warnings (tendon rupture, peripheral neuropathy, aortic dissection) 5, 1
Common Pitfalls to Avoid
- Do not prescribe the 3-day regimen for men: Men require 7 days minimum; the 3-day course is inadequate 1, 3
- Do not use Bactrim without knowing local resistance rates: Many communities now exceed the 20% threshold 1
- Do not treat asymptomatic bacteriuria: This promotes resistance without clinical benefit 5
- Do not use amoxicillin or ampicillin empirically: Worldwide E. coli resistance exceeds 30% 1, 3
- Do not fail to adjust dose when CrCl <30 mL/min: This significantly increases toxicity risk 2
- Do not use Bactrim for "borderline" upper-tract symptoms: Any flank pain or low-grade fever warrants a different agent 5
Management of Treatment Failure
If symptoms have not resolved by day 3 of therapy or recur within 2 weeks:
- Obtain urine culture with susceptibility testing immediately 5, 1
- Switch to a different antibiotic class for a full 7-day course 5
- Do not repeat a short-course regimen 5
- Presumptive cause is resistance to the initial agent 1
When to Obtain Urine Culture
Do not obtain routine culture for straightforward uncomplicated cystitis in otherwise healthy women. 1
Obtain culture and susceptibility testing when:
- Persistent symptoms after completing therapy 5, 1
- Recurrence of symptoms within 2–4 weeks 5, 1
- Fever, flank pain, or systemic signs suggesting pyelonephritis 1
- Atypical presentation or accompanying vaginal discharge 1
- Pregnancy (any trimester) 1
Decision-Making Algorithm
- Confirm uncomplicated lower UTI: Dysuria, urgency, frequency, or suprapubic discomfort without fever, flank pain, or systemic symptoms 5
- Verify local E. coli TMP-SMX resistance <20% and no patient exposure in past 3 months 1
- If criteria met: Prescribe TMP-SMX 160/800 mg twice daily for 3 days (women) or 7 days (men) 1
- If resistance ≥20% or unknown: Choose nitrofurantoin 100 mg twice daily for 5 days or fosfomycin 3 g single dose 5, 1
- If symptoms persist or recur: Obtain urine culture and switch to a different antibiotic class for 7 days 5, 1
- Adjust for renal function: Use half-dose when CrCl 15–30 mL/min; avoid when CrCl <15 mL/min 2